{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:36:04Z","timestamp":1780673764921,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.4158\/ep-2019-0610","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T14:19:25Z","timestamp":1601475565000},"page":"997-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aromatase Inhibitor Increases the Height of Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency"],"prefix":"10.1016","volume":"26","author":[{"given":"Wang","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangfeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0610_bb0010","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0015","first-page":"1511","article-title":"Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia","volume":"86","author":"Quintos","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1515\/jpem-2015-0406","article-title":"Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China","volume":"29","author":"Juan","year":"2016","journal-title":"J Pediatr Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1687-9856-2015-4","article-title":"A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature","volume":"2015","author":"Rothenbuhler","year":"2015","journal-title":"Int J Pediatr Endocrinol."},{"key":"10.4158\/EP-2019-0610_bb0030","first-page":"CD10888","article-title":"Aromatase inhibitors for short stature in male children and adolescents","volume":"10","author":"McGrath","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.4158\/EP-2019-0610_bb0035","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0040","doi-asserted-by":"crossref","first-page":"e20160730","DOI":"10.1542\/peds.2016-0730","article-title":"Growth hormone with aromatase inhibitor may improve height in CYP11B1 congenital adrenal hyperplasia","volume":"139","author":"Hawton","year":"2017","journal-title":"Pediatrics."},{"key":"10.4158\/EP-2019-0610_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13633-015-0008-0","article-title":"Height augmentation in 11beta-hydroxylase deficiency congenital adrenal hyperplasia","volume":"2015","author":"Nour","year":"2015","journal-title":"Int J Pediatr Endocrinol."},{"key":"10.4158\/EP-2019-0610_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/03014468400007151","article-title":"BASIC programs for the assessment of skeletal maturity and the prediction of adult height using the Tanner-Whitehouse method","volume":"11","author":"Cameron","year":"1984","journal-title":"Ann Hum Biol."},{"key":"10.4158\/EP-2019-0610_bb0055","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0060","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1210\/jc.2004-2128","article-title":"Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia","volume":"90","author":"Lin-Su","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40618-016-0486-9","article-title":"Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis","volume":"39","author":"Liu","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP-2019-0610_bb0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2265.2006.02499.x","article-title":"Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty","volume":"64","author":"Hero","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP-2019-0610_bb0075","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1210\/jc.2016-2891","article-title":"Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature","volume":"101","author":"Mauras","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0080","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000315482","article-title":"A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature","volume":"74","author":"Salehpour","year":"2010","journal-title":"Horm Res Paediatr."},{"key":"10.4158\/EP-2019-0610_bb0085","first-page":"625","article-title":"Letrozole as a booster therapy in growth hormone deficiency","volume":"46","author":"Kumar","year":"2009","journal-title":"Indian Pediatr."},{"key":"10.4158\/EP-2019-0610_bb0090","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1515\/jpem-2011-0435","article-title":"Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature","volume":"25","author":"Krebs","year":"2012","journal-title":"J Pediatr Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40618-015-0399-z","article-title":"Anastrozole plus leuprorelin in early maturing girls with compromised growth: the \u201cGAIL\u201d study","volume":"39","author":"Papadimitriou","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP-2019-0610_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2014.40","article-title":"Pros and cons of GnRHa treatment for early puberty in girls","volume":"10","author":"Willemsen","year":"2014","journal-title":"Nat Rev Endocrinol."},{"key":"10.4158\/EP-2019-0610_bb0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2007-1559","article-title":"Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years","volume":"93","author":"Mauras","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2019-0610_bb0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/cen.14009","article-title":"Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: impact of anastrozole on bone mineral density and visceral adipose tissue","volume":"91","author":"Halper","year":"2019","journal-title":"Clin Endocrinol (Oxf)."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2048228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2048228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:43Z","timestamp":1761516583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2048228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1530891X2048228X"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0610","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aromatase Inhibitor Increases the Height of Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}